行情

CBPO

CBPO

泰邦生物
NASDAQ

实时行情|Nasdaq Last Sale

116.38
-0.40
-0.34%
盘后: 116.38 0 0.00% 17:01 02/18 EST
开盘
116.67
昨收
116.78
最高
116.70
最低
116.02
成交量
9.82万
成交额
--
52周最高
119.44
52周最低
79.06
市值
44.74亿
市盈率(TTM)
28.63
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CBPO 新闻

  • 中金:19支中概股有望回归港股 潜在融资规模料约340亿美元
  • 新浪财经.1天前
  • 中概股“最美的花”都要回港股二次上市?
  • 新浪财经-自媒体综合.01/02 23:40
  • 7 Ideal Mid-Cap Stocks for a Diverse Portfolio
  • InvestorPlace.2019/12/20 12:02
  • 5 Top-Performing Chinese Stocks in 2019
  • GuruFocus.com.2019/12/16 22:42

更多

所属板块

生物技术和医学研究
+0.77%
制药与医学研究
-0.10%

热门股票

名称
价格
涨跌幅

CBPO 简况

China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC).
展开

Webull提供China Biologic Products Holdings Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。